Unknown PHASE4 INTERVENTIONAL 3-arm NCT01926834

The Effect of Erigeron Injection on Acute Cerebral Infarction Serum VEGF, MMP-9 and EPC Levels

Sponsor: Guangzhou University of Traditional Chinese Medicine

Interventions Erigeron Injection placebo

Updated 4 times since 2017 Last updated: Aug 19, 2013 Started: Aug 31, 2013 Primary completion: Aug 31, 2013 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cerebral Infarction and is currently ongoing. Guangzhou University of Traditional Chinese Medicine leads this study, which shows 4 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE4

First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guangzhou University of Traditional Chinese Medicine

Data source: Guangzhou University of Traditional Chinese Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.